Fighting PBMs, advocacy and what full-scope can really look like: A friendly cross-border pharmacy collabLeaders from major U.S. pharmacy banners and associations met with their Canadian counterparts in Toronto this past week in an effort to share experiences, wisdom and lessons learned. Ontario signs $176 million deal with feds for rare disease treatmentsThe three-year deal will fund the availability of five drugs and support improvements for early screening and diagnostic testing for rare diseases. Why do we make it so hard for patients to access Paxlovid? We have a treatment that works for people who get COVID-19. Why are so few of the patients who could benefit from it able to access it? OCP delays decision on official PPN stance More time and advice needed for board to make an informed decision, College says.
